Tech Company Financing Transactions
Amulet Pharmaceuticals Funding Round
On 1/18/2007, Amulet Pharmaceuticals raised $1.7 million in financing from Wilmington Investor Network.
Transaction Overview
Company Name
Announced On
1/18/2007
Transaction Type
Venture Equity
Amount
$1,700,000
Round
Undisclosed
Investors
Wilmington Investor Network (Lead Investor)
Proceeds Purpose
"The infusion of capital
will enable us to accelerate our growth and commercialization strategy -- focusing on securing
license agreements," said CEO Craig Liddell, Ph.D.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
One Research Ct. 450
Rockville, MD 20850
USA
Rockville, MD 20850
USA
Phone
Website
Email Address
Overview
Amulet was founded in 2001 by Dr. Robert Raulli Ph.D., a leader in Nitric Oxide based therapeutics. During the first 3 years of operations, Amulet developed it's own novel composition--of-matter intellectual property (NORTECH) and began segmenting it's NORTECH technology into dozens of well defined markets.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Carlos Parajon
Browse more venture capital transactions:
Prev: 1/18/2007: meebo venture capital transaction
Next: 1/18/2007: Workshare venture capital transaction
Share this article
News on VC Transactions
We do our best to document funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs